ABX Pentra ML血液学检查多链接系统

一种新型多链接系统允许最多3台血液学分析仪连接到同一台验证工作站，使得单个血液学实验室经过设置，每天可以处理2000个样本。

这套系统叫做ABX Pentra ML，设计与Horiba ABX血液学分析仪配套使用。ABX Pentra ML允许该公司任何型号的ABX Pentra或者Micros血液分析仪通过任何方式进行连接。所有结果能够被集中在同一屏幕的中央，自动或者人工进行验证。

Horiba使用ABX Pentra120分析仪，整合了叫做Double Diff Matrix的独特工艺。这种特性能够显著减低人工之间的差异，允许科学家首次能够区别与白细胞生成相关的三种重要细胞系。Double Diff Matrix工艺联合使用流式细胞技术与细胞化学技术，能够常规鉴别与定量检查3种在白细胞生成中未成熟的细胞系：粒细胞、淋巴细胞、单核细胞。由于真正反映检测结果，重新检查的切片数量得以减少，血液科医生能够得到快速报告从而能够快速做出决定。ABX Pentra DF120每小时提供32种参数处理120例样本，同时一个专家确认工作站能够自动对结果进行确认以及验证。
 
Multilink Speeds Hematology Analysis
 
A new multilink system allows up to three hematology analyzers to be connected to the same validation station, enabling hematology laboratories to handle up to 2,000 samples per day with configurations tailored to individual lab requirements.

The system, called ABX Pentra ML, is designed for use with the hematology analyzers of Horiba ABX (Montpellier, France). The ABX Pentra ML allows any model from the company’s ABX Pentra or Micros hematology analyzer line to be linked in any combination. All results can be centralized on the same screen to be validated automatically or manually.

Horiba has launched a new line of ABX Pentra 120 analyzers that incorporate exclusive technology called Double Diff Matrix. This feature significantly reduces manual differentials, enabling scientists for the first time to distinguish three key cell lines involved in leukopoiesis. Double Diff Matrix technology combines flow cytometry and cytochemistry to provide routine identification and quantification of the three immature lines involved in leukopoiesis: granulocytic, lymphocytic, and monocytic. Thanks to true reflex testing, the number of slide re-examinations is reduced and the hematologist receives a fast report enabling rapid decision-making. The ABX Pentra DF 120 offers 32 parameters and 120 samples per hour, while an expert validation station provides automatic confirmation and validation of results.